More News

16 Jul 2019 Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech
16 Jul 2019 Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California
15 Jul 2019 AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
15 Jul 2019 Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
15 Jul 2019 Recordati to acquire worldwide rights to Signifor® and Osilodrostat (LCI699)
15 Jul 2019 Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
12 Jul 2019 Genmab and BliNK Biomedical Enter into Commercial License Agreement
11 Jul 2019 Report Package: Bispecific Antibodies
11 Jul 2019 vasopharm Closes € 9.5 million Financing Round
10 Jul 2019 AiCuris and Lysando join forces in the fight against antimicrobial resistance
10 Jul 2019 Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
09 Jul 2019 Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
09 Jul 2019 Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
09 Jul 2019 Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
09 Jul 2019 IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
09 Jul 2019 ADC Therapeutics Announces Final Close of Series E Financing Expansion
09 Jul 2019 BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
09 Jul 2019 MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
08 Jul 2019 Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
08 Jul 2019 Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
08 Jul 2019 Eisai enters into collaboration research agreement with University of Dundee on targeted protein degradation toward cancer drug discovery
03 Jul 2019 Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)
03 Jul 2019 New partnership to advance Nosopharm’s lead candidate to clinical stage and develop second drug candidate
03 Jul 2019 Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds
02 Jul 2019 Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up